This is the first crowdlending campaign in Portugal for a project in this industry.
“This campaign marks our first Danish promoter, and it is the first time that Goparity has offered an investment opportunity in one of the industries with the greatest growth and potential today: medicinal cannabis. It is always a pleasure to see crowd lending working as a catalyst for projects that contribute to a healthier, more developed, and sustainable society”, says Nuno Brito Jorge, CEO and co-founder of Goparity, quoted in a press release.
The crowd lending campaign, the first in Portugal for a medicinal cannabis project, opened on August 14 and attracted a total of 1,774 investors from 23 countries, of which six were companies – totalling €8,050– and the rest were individuals. The largest investment was €10,000 and the average was around €170.98 per investor, according to a press release.
“This type of financing plays a central role in the growth of Valcon Medical, allowing us to accelerate our projects and bring our innovations to market more quickly,” says Pete Patterson, CEO of Valcon Medical.
This funding will enable Valcon Medical to expand its production, carry out technological upgrades and expand its operations in a sector that “has shown promise in reducing opioid dependence and as a viable alternative to help manage symptoms of conditions such as chronic pain, multiple sclerosis (MS), epilepsy, spinal cord injuries and cancer-related symptoms”, the statement said.
In November 2023, Goparity surpassed the target of €30 million invested by more than 15 thousand individuals and companies, with projects financed through the platform having positively impacted around 89 thousand people, created almost 5,000 jobs and contributed to avoiding the emission of 25,000 tons of CO2 emissions into the atmosphere every year, according to data shared by the platform.